Maia Hembruff

Discussing safety amidst development of new HIV preventative

Amidst the development of a new HIV preventative drug, University of Rhode Island faculty and staff are working to expand accessibility resources and diminish stigmas around HIV prevention. Lenacapavir is a newly developed pre-exposure prophylaxis, or preventative, drug taken twice yearly to stop HIV transmission, according to Dr. Christopher Nasin, the medical director at Health…

Read More